Showing 1 - 2 results of 2 for search 'Masataka Tanimoto', query time: 0.02s Refine Results
  1. 1
    Relugolix for oral treatment of uterine leiomyomas: a dose-finding, randomized, controlled trial

    Relugolix for oral treatment of uterine leiomyomas: a dose-finding, randomized, controlled trial by Hiroshi Hoshiai, Yoshifumi Seki, Takeru Kusumoto, Kentarou Kudou, Masataka Tanimoto

    Published 2021-10-01
    Get full text
    Article
  2. 2
    Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results

    Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results by Yutaka Osuga, Yoshifumi Seki, Masataka Tanimoto, Takeru Kusumoto, Kentarou Kudou, Naoki Terakawa

    Published 2021-06-01
    Get full text
    Article

Search Tools: